Please use this identifier to cite or link to this item:
http://repository.tma.uz/xmlui/handle/1/2513
Title: | Experience of using montiget in patients with bronchial asthma of moderate to severe course |
Authors: | Zufarov P.S., Saidova Sh.A., Akbarova D.S., Musaeva L.J, Pulatova D.B., Abdumajidova N.H |
Keywords: | Experience of using montiget, moderate to severe course |
Issue Date: | 2022 |
Publisher: | Toshkent |
Abstract: | 50 patients aged from 35 to 67 years inclusive with the diagnosis of BA were included in the study. The patients were divided into 2 groups by random sampling. Patients of the first group (control group) -25 people received basic therapy with inhaled glucocorticosteroids and long-acting p2-agonists in the form of combined preparation of Seretide 25/250 meg or 25/500 meg 2 times daily. Patients of the second group -25 people received 25/250 or 50/250 meg Seretide twice a day, and also leukotriene receptor inhibitor Montiget in a dose of 10 mg once daily |
URI: | http://repository.tma.uz/xmlui/handle/1/2513 |
Appears in Collections: | Thesis, Articles |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
5.pdf | Experience of using montiget in patients with bronchial asthma of moderate to severe course | 199.35 kB | Adobe PDF | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.